Literature DB >> 11829458

Long-term expression after infection by the hybrid vector AdLTR-luc is from integrated transgene.

Changyu Zheng1, Bruce J Baum.   

Abstract

The novel adenoretroviral vector, AdLTR-luc, infects dividing and nondividing cells, and mediates long-term transgene expression(Zheng, C., Baum, B. J., Iadarola, M. J., and O'Connell, B. C., Nat. Biotech. 18, 176-180, 2000). To determine the source of this expression we examined two epithelial cell lines. One, HSG, permits E1(-) recombinant adenoviral replication, while the other, A5, does not. An HSG clone, that expressed luciferase stably for > 6 months, was obtained following infection at approximately 0.2 AdLTR-luc particles/cell. Southern and PCR analyses showed that luciferase cDNA present was integrated. A5 cells were infected with AdLTR-luc at approximately 1000 particles/cell, and colonies were obtained by limiting dilution. Eight clones showed stable luciferase activity for > 9 months. High molecular weight DNA extracts from clones were positive for genomic integration by Southern, PCR, and quantitative PCR analyses. Similar analyses of low molecular weight DNA extracts indicated the absence of intact extrachromosomal vector. These data demonstrate that long-term luciferase expression after infection by AdLTR-luc is derived from the integrated cDNA. ©2002 Elsevier Science (USA).

Mesh:

Substances:

Year:  2002        PMID: 11829458     DOI: 10.1006/bbrc.2002.6401

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

1.  A novel hybrid adenoretroviral vector with more extensive E3 deletion extends transgene expression in submandibular glands.

Authors:  Changyu Zheng; Ana P Cotrim; Nikolay Nikolov; Fumi Mineshiba; William Swaim; Bruce J Baum
Journal:  Hum Gene Ther Methods       Date:  2012-07-20       Impact factor: 2.396

2.  Extended transgene expression from a nonintegrating adenoviral vector containing retroviral elements.

Authors:  Changyu Zheng; Joseph M Vitolo; Weitian Zhang; Fumi Mineshiba; John A Chiorini; Bruce J Baum
Journal:  Mol Ther       Date:  2008-03-25       Impact factor: 11.454

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.